Eli Lilly to Acquire Merida Biosciences for Up To $2.875 Billion

Goodwin Procter has advised Merida Biosciences. Ropes & Gray has advised Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) and Merida Biosciences, Inc. have…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here